We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+27.18%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$555M
AUM Growth
+$80.2M
Cap. Flow
+$43.8M
Cap. Flow %
7.88%
Top 10 Hldgs %
63.82%
Holding
63
New
15
Increased
13
Reduced
3
Closed
16

Top Buys

Rank Stock Value
1
PLAB icon
Photronics
PLAB
+$17.7M
2
PDFS icon
PDF Solutions
PDFS
+$16.1M
3
CYBE
Cyberoptics Corp
CYBE
+$13.8M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$12.1M
5
PDSB icon
PDS Biotechnology
PDSB
+$11.7M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$27.9M
2
RMNI icon
Rimini Street
RMNI
+$10.6M
3
NVVE
Nuvve Holding Corp
NVVE
+$7.62M
4
SBBP
Strongbridge Biopharma plc.
SBBP
+$6.06M
5
LPTH icon
Lightpath Technologies
LPTH
+$5.75M

Sector Composition

Rank Sector Weight
1 Technology 26.4%
2 Healthcare 24.43%
3 Industrials 4.2%
4 Consumer Staples 0.53%
5 Financials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
26
DELISTED
Alimera Sciences
ALIM
$4.56M 0.82%
501,025
– –
WTT
27
DELISTED
Wireless Telecom Group, Inc.
WTT
$4.4M 0.79%
+1,080,348
New +$2.1M
BKTI icon
28
BK Technologies
BKTI
$300M
$4.22M 0.76%
+268,000
New +$5.4M
SCPH
29
DELISTED
scPharmaceuticals
SCPH
$3.92M 0.71%
642,154
-212,988
-25% -$1.28M
ICLN icon
30
PUT
iShares Global Clean Energy ETF
ICLN
$2.35B
$3.75M 0.68%
+160,000
New +$3.65M
RFIL icon
31
RF Industries
RFIL
$135M
$3.69M 0.67%
+495,037
New +$3.5M
HTGM
32
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$3.56M 0.64%
51,000
+31,667
+164% +$1.71M
ARDS
33
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$3.33M 0.6%
459,261
+35,904
+8% +$224K
PCSA icon
34
Processa Pharmaceuticals
PCSA
$5.9M
$3.17M 0.57%
774
– –
YTEN
35
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.92M 0.53%
14,250
-1,583
-10% -$352K
DAIO icon
36
Data I/O
DAIO
$30.4M
$2.85M 0.51%
418,310
+40,000
+11% +$238K
TAOX
37
Tao Synergies Inc
TAOX
$27.3M
$2.83M 0.51%
+12,678
New +$2.97M
MDNA
38
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$2.77M 0.5%
915,000
+75,000
+9% +$277K
NVNO
39
enVVeno Medical
NVNO
$7.14M
$2.38M 0.43%
9,911
-2,334
-19% -$501K
EVOK
40
DELISTED
Evoke Pharma
EVOK
$2.33M 0.42%
11,814
+1,862
+19% +$399K
DCOY
41
Decoy Therapeutics
DCOY
$2.31M
$1.91M 0.34%
50
– –
IPWR icon
42
Ideal Power
IPWR
$63.6M
$1.83M 0.33%
+144,347
New +$1.56M
CYTHW
43
CALL
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$1.81M 0.33%
+350,000
New +$1.29M
HSDT icon
44
Solana Company
HSDT
$98.1M
$1.72M 0.31%
3
– –
NLSPW
45
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$872K 0.16%
+827,921
New +$734K
BLIN icon
46
Bridgeline Digital
BLIN
$14.7M
– –
-177,419
Closed -$512K
COHU icon
47
Cohu
COHU
$2.3B
– –
-665,853
Closed -$27.9M
HYPD
48
Hyperion DeFi Inc
HYPD
$40.3M
– –
-998
Closed -$408K
GANX icon
49
Gain Therapeutics
GANX
$74.6M
– –
-65,809
Closed -$982K
GRI
50
GRI Bio
GRI
$2.55M
– –
0
– -$95K
1
2
3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $737M AUM 17.98% 1-Year Est. Return

AIGH Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, AIGH Capital Management held 63 positions worth $555M, up 17% from $475M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

AIGH Capital Management deployed $43.8M of net new capital in Q2 2021, opening 15 new positions and adding to 13 existing holdings. Its largest new stake was Photronics: 1,350,734 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was scPharmaceuticals, an estimated $1.28M trimmed.

  • AIGH Capital Management's largest Q2 2021 buy was Photronics: 1,350,734 shares worth $17.8M.
  • AIGH Capital Management added most to Galera Therapeutics, Inc. Common Stock in Q2 2021, an estimated $9.02M increase.
  • AIGH Capital Management's biggest Q2 2021 reduction was scPharmaceuticals, cutting an estimated $1.28M.
  • AIGH Capital Management fully exited Cohu in Q2 2021, selling an estimated $27.9M.
  • AIGH Capital Management's ten largest holdings make up 64% of its $555M portfolio in Q2 2021.
  • AIGH Capital Management opened 15 new positions and closed 16 in Q2 2021.
  • AIGH Capital Management's portfolio value rose 17% quarter-over-quarter to $555M.

Based on AIGH Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.